Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anterix (ATEX) EBT Margin (2016 - 2025)

Anterix's EBT Margin history spans 13 years, with the latest figure at 550.1% for Q4 2025.

  • For Q4 2025, EBT Margin fell 102749.0% year-over-year to 550.1%; the TTM value through Dec 2025 reached 1436.38%, up 192609.0%, while the annual FY2025 figure was 157.19%, 2212.0% up from the prior year.
  • EBT Margin reached 550.1% in Q4 2025 per ATEX's latest filing, down from 3933.89% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 3933.89% in Q3 2025 to a low of 6518.68% in Q2 2021.
  • Average EBT Margin over 5 years is 1073.06%, with a median of 782.74% recorded in 2024.
  • Peak YoY movement for EBT Margin: surged 586818bps in 2023, then crashed -341824bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 3195.58% in 2021, then skyrocketed by 58bps to 1351.21% in 2022, then surged by 110bps to 131.08% in 2023, then skyrocketed by 264bps to 477.39% in 2024, then tumbled by -215bps to 550.1% in 2025.
  • Per Business Quant, the three most recent readings for ATEX's EBT Margin are 550.1% (Q4 2025), 3933.89% (Q3 2025), and 1616.57% (Q2 2025).